Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bacteremia caused by Acinetobacter ursingii.

Julien Loubinoux1, Liliana Mihaila-Amrouche, Anne Le Fleche

  • 1Service de Microbiologie. Service de Pneumologie, Hôtel Dieu Assistance Publique-Hôpitaux de Paris, Université Paris VI, 75181 Paris Cedex 04, France. j.loubinoux@voila.fr

Journal of Clinical Microbiology
|March 8, 2003
PubMed
Summary

Acinetobacter ursingii, a newly described bacterium, has been identified as an opportunistic pathogen causing bacteremia in a patient with lung cancer. This finding highlights its potential role in human infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbiology and outcomes of tubo-ovarian abscesses: A 5-year cohort of 105 cases.

The Journal of infection·2024
Same author

High-level expression of chromosomally encoded SHV-1 β-lactamase reduces the susceptibility to cefiderocol of clinical isolates of Klebsiella pneumoniae.

The Journal of antimicrobial chemotherapy·2024
Same author

Rahnella sikkimica sp. nov., a novel cold-tolerant bacterium isolated from the glacier of Sikkim Himalaya with plant growth-promoting properties.

Extremophiles : life under extreme conditions·2022
Same author

The genus Serratia revisited by genomics.

Nature communications·2022
Same author

Experimental study on the quasi-steady approximation of glottal flows.

The Journal of the Acoustical Society of America·2022
Same author

Doxycycline versus azithromycin for the treatment of anorectal Chlamydia trachomatis infection in women concurrent with vaginal infection (CHLAZIDOXY study): a multicentre, open-label, randomised, controlled, superiority trial.

The Lancet. Infectious diseases·2022

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Acinetobacter ursingii was recently identified as a distinct bacterial species.
  • Limited information exists regarding its role in human pathogenesis.

Observation:

  • A case of bacteremia caused by Acinetobacter ursingii occurred in a patient diagnosed with pulmonary adenocarcinoma.
  • This represents a novel infectious process associated with this microorganism.

Findings:

  • The study confirms Acinetobacter ursingii as an opportunistic human pathogen.
  • Antimicrobial susceptibility testing revealed the isolate was sensitive to imipenem, aminoglycosides, rifampin, and fluoroquinolones.

Implications:

  • This case expands the known spectrum of Acinetobacter ursingii infections.

Related Experiment Videos

  • Understanding the pathogenicity and antimicrobial susceptibility of A. ursingii is crucial for clinical management.
  • Further research is warranted to investigate the prevalence and clinical significance of A. ursingii in human infections.